Document is current
Any future updates will be listed below
-
Authors
Alushaj, Erind
Berman, Gabriele https://orcid.org/0009-0008-3390-9508
Mollan, Susan P. https://orcid.org/0000-0002-6314-4437
Simpson, Sarah M.
Lowe, Michael https://orcid.org/0000-0001-5712-3800
- License Information
-
More Information
Article History
Received: 29 January 2026
Revised: 3 February 2026
Accepted: 11 February 2026
First Online: 20 February 2026
Competing interests
: ML reports speaker fees (Pfizer); travel (AbbVie, Teva, Lundbeck). SM reports consultancy fees (Invex Therapeutics); advisory board fees (Ocular therapeutix); speaker fees (Teva); travel (AbbVie and European Alliance of Associations for Rheumatology); Receipt of equipment (Heidelberg Engineering). SM is a section editor at Eye Journal. Authors declare no other financial relationships with any organisations that might have an interest in the submitted work; and no other relationships or activities that could appear to have influenced the submitted work.
